Why Dural Arteriovenous Fistulas Treatment Is Gaining Clinical Attention
The global dural arteriovenous fistulas treatment market is expanding against a backdrop of rising healthcare expenditure, advancements in medical technology, and increasing research and development activities. The market was valued at USD 2.31 billion in 2025 and is projected to reach USD 4.72 billion by 2035, registering a CAGR of 7.41% over the forecast period. What makes this market particularly notable is the shift toward minimally invasive endovascular interventions that reduce recovery times, minimize complications, and improve patient outcomes—alongside growing awareness among healthcare professionals that is driving earlier diagnosis and treatment.
At a Glance: Dural Arteriovenous Fistulas Treatment Market
-
2024 market size: USD 2.148 billion
-
2025 estimated size: USD 2.307 billion
-
2035 projected size: USD 4.716 billion
-
CAGR (2025–2035): 7.41%
-
Largest treatment type segment: Endovascular Intervention (projected to reach USD 1.892 billion by 2035)
-
Fastest-growing treatment type segment: Surgery
-
Largest procedure type segment: Transarterial Embolization (Surgical Excision projected to reach USD 1.442 billion by 2035)
-
Largest diagnosis type segment: Magnetic Resonance Imaging (projected to reach USD 1.9 billion by 2035)
-
Fastest-growing diagnosis type segment: Digital Subtraction Angiography
-
Largest patient type segment: Adult (Pediatric projected to reach USD 1.89 billion by 2035)
-
Largest healthcare setting segment: Hospitals (projected to reach USD 1.895 billion by 2035)
-
Fastest-growing healthcare setting segment: Ambulatory Surgical Centers
Rising Healthcare Expenditure Drives Demand
An increase in healthcare expenditure across various regions is propelling the market. As governments and private sectors allocate more funds towards healthcare, there is a corresponding rise in the availability of advanced treatment options for conditions like DAVFs. This financial commitment enables healthcare providers to invest in state-of-the-art technologies and training, ultimately improving patient care. Moreover, higher healthcare spending often correlates with increased patient access to specialized treatments, which is crucial for conditions that require timely intervention. As a result, the market is likely to experience robust growth driven by enhanced funding and resource allocation.
Advancements in Medical Technology Enhance Treatment Precision
Technological advancements in medical devices and treatment methodologies are significantly influencing the market. Innovations such as improved imaging techniques, including high-resolution MRI and CT angiography, facilitate accurate diagnosis and treatment planning. Additionally, the development of advanced endovascular techniques, such as embolization, has revolutionized treatment approaches, offering less invasive options with reduced recovery times. These advancements not only enhance patient outcomes but also attract more healthcare facilities to adopt these technologies, thereby driving market growth. The integration of artificial intelligence in diagnostic processes further streamlines treatment pathways, indicating a promising future for the market.
Increase in Research and Development Activities Supports Innovation
The surge in research and development activities related to dural arteriovenous fistulas is significantly influencing the market. Pharmaceutical companies and medical device manufacturers are increasingly investing in R&D to develop innovative treatment solutions. This focus on research is likely to yield new therapeutic options and improve existing treatments, thereby enhancing patient outcomes. Furthermore, collaborations between academic institutions and industry players are fostering a conducive environment for innovation. As new findings emerge and treatment methodologies evolve, the market is expected to expand, driven by a continuous influx of novel solutions.
Endovascular Intervention Dominates, While Surgery Grows Fastest
In the treatment type segment, Endovascular Intervention holds the largest market share due to its minimally invasive nature and favorable patient outcomes. This technique has gained significant acceptance among healthcare providers, capturing the attention of many practitioners in neurosurgery and interventional radiology. Surgery, while traditionally a standard treatment, is increasingly being complemented by endovascular methods, leading to a shift in treatment preferences among clinicians and patients alike. The Surgery segment, although currently smaller in market share, is identified as the fastest-growing segment. Increased demand for surgical intervention arises from the need for complex cases, where endovascular techniques may not be sufficient. Technological advancements, alongside better pre-and post-operative care, are enhancing surgical outcomes and contributing to its growth.
Looking for more in-depth data on the dural arteriovenous fistulas treatment market? Get this report customized with inclusion of custom data sets to suit your exact business needs.
Market Dynamics: Healthcare Spending, Technology, and Research Investment
Several structural factors are supporting market growth:
-
Rising healthcare expenditure, with governments and private sectors allocating more funds towards advanced treatment options.
-
Advancements in medical technology, including high-resolution MRI, CT angiography, and advanced endovascular techniques.
-
Increase in research and development activities, with pharmaceutical companies and medical device manufacturers investing in innovative treatment solutions.
-
Growing awareness among healthcare professionals, with continuous medical education programs focusing on vascular conditions.
-
Increasing incidence of dural arteriovenous fistulas, with better diagnostic techniques and heightened awareness leading to more identified cases.
-
Aging population, which is more susceptible to vascular conditions, contributing to market expansion.
Dural Arteriovenous Fistulas Treatment Market Outlook, 2025–2035
The market is projected to grow at a 7.41% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising patient populations. New opportunities lie in the development of minimally invasive treatment devices for outpatient procedures, expansion of telemedicine platforms for remote patient monitoring and consultations, and strategic partnerships with healthcare providers for integrated treatment pathways. By 2035, the market is expected to reach USD 4.72 billion, with North America maintaining dominance and Asia-Pacific emerging as the fastest-growing region due to increasing healthcare expenditure and rising awareness of neurological disorders.
Key Companies
Companies profiled in the dural arteriovenous fistulas treatment market include:
-
Medtronic (US)
-
Stryker (US)
-
Boston Scientific (US)
-
Terumo Corporation (JP)
-
Johnson & Johnson (US)
-
Abbott Laboratories (US)
-
B. Braun Melsungen AG (DE)
-
Penumbra, Inc. (US)
Explore the full list of profiled companies operating in this market with recent strategic initiatives — View Company Profiles
Explore our dedicated business services:
-
Go-To-Market (GTM) Strategy – Accelerate market entry and maximize ROI with market entry roadmaps, customer segmentation, product-market fit assessment, channel strategy, pricing and positioning, and digital GTM advisory.
-
Deep Dive Competitive Intelligence – Gain 360° visibility on competitors through benchmarking and SWOT analysis, product pipeline tracking, M&A monitoring, and pricing and distribution tracking.
-
Feasibility Assessments – Evaluate the commercial, technical, and operational viability of an initiative before deployment, including demand analysis, regulatory environment assessment, and ROI payback modeling.
-
Granular Research & Custom Insights – Answer specific and complex business questions through segment-level market sizing, micro-regional analysis, niche buyer journey studies, and sub-category demand forecasts.
-
Thought Leadership & Whitepapers – Position your brand as a category leader with data-backed publications and future outlooks.
-
Supply Chain Intelligence – Track suppliers, cost structures, and sourcing dynamics to improve resilience and savings.
-
Data Modeling & Predictive Analytics – Leverage machine learning, statistical forecasting, and econometrics for better planning.
About us:
Market Research Future (MRFR) is a global market research company that offers comprehensive and accurate analysis of diverse markets and consumers worldwide. MRFR combines proprietary information with multiple data sources to give clients an extensive understanding of key developments, expected events, and the actions to take based on those insights. The firm is backed by a proficient team of research analysts who provide valuable analytics on technological and economic advancements, conduct industrial visits, and procure relevant information from prominent market players. MRFR's key objective is to keep clients informed of potential opportunities and challenges across markets, providing step-by-step assistance through strategic and consulting services to reach managerial and actionable decisions. MRFR (Part of WantStats Research and Media Pvt. Ltd.) specializes in industries including Aerospace & Defense, Automotive, Chemicals & Materials, Energy & Power, Food & Beverage, Healthcare & Pharmaceutical, ICT, Industrial Equipment, Packaging, Construction & Mining, and Semiconductor.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Giochi
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Altre informazioni
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness